Strategic Shifts and Technological Surge Define the Global Cancer Diagnostics Landscape as Market Eyes $176 Billion Horizon
The global cancer diagnostics market, a critical pillar in the ongoing war against cancer, is undergoing a period of unprecedented transformation. Driven by a surge in strategic mergers and acquisitions (M&A), relentless innovation in genomic…
5 mins read